SCTR
Secretin receptor
Also known as: SCTR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47872
- Gene
- SCTR
- Ensembl
- ENSG00000080293
- Chromosome
- 2
- Canonical length
- 440 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a G protein-coupled receptor and belongs to the glucagon-VIP-secretin receptor family. It binds secretin which is the most potent regulator of pancreatic bicarbonate, electrolyte and volume secretion. Secretin and its receptor are suggested to be involved in pancreatic cancer and autism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
440 residues, UniProt reviewed canonical sequence.
>P47872|SCTR
1 MRPHLSPPLQ QLLLPVLLAC AAHSTGALPR LCDVLQVLWE EQDQCLQELS REQTGDLGTE
61 QPVPGCEGMW DNISCWPSSV PGRMVEVECP RFLRMLTSRN GSLFRNCTQD GWSETFPRPN
121 LACGVNVNDS SNEKRHSYLL KLKVMYTVGY SSSLVMLLVA LGILCAFRRL HCTRNYIHMH
181 LFVSFILRAL SNFIKDAVLF SSDDVTYCDA HRAGCKLVMV LFQYCIMANY SWLLVEGLYL
241 HTLLAISFFS ERKYLQGFVA FGWGSPAIFV ALWAIARHFL EDVGCWDINA NASIWWIIRG
301 PVILSILINF ILFINILRIL MRKLRTQETR GNEVSHYKRL ARSTLLLIPL FGIHYIVFAF
361 SPEDAMEIQL FFELALGSFQ GLVVAVLYCF LNGEVQLEVQ KKWQQWHLRE FPLHPVASFS
421 NSTKASHLEQ SQGTCRTSIILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCTR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 64 nTPM
- duodenum: 25 nTPM
- kidney: 11 nTPM
- lung: 8.1 nTPM
- stomach: 4.1 nTPM
- small intestine: 3.5 nTPM
Single-cell type
- pancreatic duct cells: 520 nCPM
- loop of henle epithelial cells: 138 nCPM
- adipocytes: 84 nCPM
- alveolar cells type 2: 76 nCPM
- gastric progenitor cells: 60 nCPM
- epicardial cells: 57 nCPM
Immune cell
- basophil: 0.6 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 2.2 nTPM
- cerebral cortex: 2.2 nTPM
- thalamus: 2.2 nTPM
- pons: 2 nTPM
- white matter: 1.9 nTPM
- hippocampal formation: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.02
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- diet induced thermogenesis
- G protein-coupled receptor signaling pathway
- intracellular water homeostasis
- regulation of appetite
- regulation of synaptic plasticity
- response to nutrient levels
Molecular functions
- G protein-coupled peptide receptor activity
- peptide hormone binding
- secretin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 2, secretin-like
- GPCR, family 2, extracellular hormone receptor domain
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- GPCR family 2, extracellular hormone receptor domain superfamily
- G-protein coupled receptor 2
- 7 transmembrane receptor (Secretin family)
- Hormone receptor domain
- GPCR, family 2, secretin receptor
- Secretin receptor, 7TM
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCTR as an antibody target. Whether an autoantibody or antibody against SCTR could matter depends on whether native SCTR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCTR is annotated at the cell surface, where native SCTR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SCTR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...